Structured Light Plethysmography as a method of recording disease severity in Cystic Fibrosis

M. Khan (Cambridge, United Kingdom), P. Set (Cambridge, United Kingdom), M. Harrison (Cambridge, United Kingdom), A. Phythian (Cambridge, United Kingdom), C. Harding (Cambridge, United Kingdom), I. Henriques-Cadby (Sheffield, United Kingdom), S. Walters (Sheffield, United Kingdom), K. Sylvester (Cambridge, United Kingdom)

Source: International Congress 2018 – Innovations in equipment and their application
Session: Innovations in equipment and their application
Session type: Poster Discussion
Number: 3392
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Khan (Cambridge, United Kingdom), P. Set (Cambridge, United Kingdom), M. Harrison (Cambridge, United Kingdom), A. Phythian (Cambridge, United Kingdom), C. Harding (Cambridge, United Kingdom), I. Henriques-Cadby (Sheffield, United Kingdom), S. Walters (Sheffield, United Kingdom), K. Sylvester (Cambridge, United Kingdom). Structured Light Plethysmography as a method of recording disease severity in Cystic Fibrosis. 3392

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of Impulse Oscillometry With Spirometry in Patients With Non Cystic Fibrosis Bronchiectasis
Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Year: 2020


Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis?
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


Comparison of the Cystic Fibrosis Questionnaire with the St George‘s Respiratory Questionnaire in adult patients with cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012

Comparative Evaluation of Clinical, Spiro/Oscillometric and Tomographic Parameters As A Global Assessment of Children With Cystic Fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF)
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021



Non Cystic Fibrosis Bronchiectasis: Results of Bronchiectasis Severity Index and Quality of Life in an Indian population
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020

Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021



Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Evaluation of the effectiveness of cyclical and constant current on sweat volume and stimulation for cystic fibroses diagnoses
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ?
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Sputum processing methods in airway disease: Which is best?
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Impact of depression on patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


Development of Barrows Cards in enhancing self-management in Pediatric patient with Cystic Fibrosis
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Quantitative evaluation of CF airways using HRCT, µCT and histology
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014